Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 765

Results For "IP"

11130 News Found

Ayurveda tech startup NirogStreet raises US $12 mn led by Jungle Ventures
News | November 21, 2022

Ayurveda tech startup NirogStreet raises US $12 mn led by Jungle Ventures

The company offers a wide portfolio of services including integrated doctor-led prescription e-commerce enablement, digital health record management, and smart clinics.


Sonowal inaugurates Regional Research Institute of Unani Medicine in Silchar
News | November 21, 2022

Sonowal inaugurates Regional Research Institute of Unani Medicine in Silchar

The newly built complex of RRIUM, which will be under CCRUM, the apex government organization for research in Unani Medicine


Pfizer and BioNTech report new data on Omicron BA.4/BA.5-adapted bivalent booster
Clinical Trials | November 21, 2022

Pfizer and BioNTech report new data on Omicron BA.4/BA.5-adapted bivalent booster

Omicron BA.5 continues to be the most prevalent sublineage in the United States (nearly 30% of cases) at the time of publication of the data


USFDA completes pre-approval inspection of BHL's Vadodara facility
Drug Approval | November 21, 2022

USFDA completes pre-approval inspection of BHL's Vadodara facility

The pre-approval inspection of USFDA was completed successfully with ZERO 483 observation of the manufacturing facilities of Bajaj Healthcare Limited


Aurobindo Pharma receives 10 observations for Unit IX
Drug Approval | November 21, 2022

Aurobindo Pharma receives 10 observations for Unit IX

The company had responded to the agency and carried out the required corrective actions.


Strides receives USFDA approval for Potassium Chloride Oral Solution
Drug Approval | November 19, 2022

Strides receives USFDA approval for Potassium Chloride Oral Solution

The approval further strengthens the Potassium Chloride franchise for the company.


Vivimed Labs Q2 FY2023 consolidated loss at Rs. 22.03 Cr
News | November 19, 2022

Vivimed Labs Q2 FY2023 consolidated loss at Rs. 22.03 Cr

The company has reported total income of Rs. 44.37 crores during the period ended September 30, 2022


Strand Life Sciences launches ‘Strand Genomic Wellness’
Biotech | November 18, 2022

Strand Life Sciences launches ‘Strand Genomic Wellness’

Strand’s new offering will help people better understand and manage diseases through genomic sequencing


Apollo launches national program to promote rational use of antibiotics
News | November 18, 2022

Apollo launches national program to promote rational use of antibiotics

Program will fight the rising incidence of antimicrobial (drug) resistance and improve patient outcomes


Zydus Lifesciences gets exclusive marketing rights for CanAssist Breast
Healthcare | November 18, 2022

Zydus Lifesciences gets exclusive marketing rights for CanAssist Breast

Zydus becomes the only Indian oncology player to venture into prognosis and diagnosis along with treatment planning